Editor(s):
(1) Dr. Zhiheng Zhou, Thyroid Cancer Research Laboratory, Massachusetts General Hospital, Harvard Medical School, USA.
Reviewers:
(1) Subodh Kumar Mahto, Anandi Prakash Hospital, India.
(2) Rosy Bavaraju, Promea Therapeutics Private Limited, India.
(3) Manisha Nagpal, Sri Guru Ram Das University of Health Sciences and Research, India.
Additional Reviewers:
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.16/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Subodh Kumar Mahto, India) | File 1 | NA
Stage 2 | Peer review report_2 (Rosy Bavaraju, India) | File 1 | File 2
Stage 2 | Peer review report_3 (Manisha Nagpal, India) | File 1 | File 2
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA